Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Kane Biotech Inc. V.KNE

Alternate Symbol(s):  KNBIF

Healthcare Biotechnology
Kane Biotech Inc. is a Canada-based biotechnology company. The Company is engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. It has a portfolio of biotechnologies and products, which includes StrixNB, DispersinB, Aledex, bluestem, bluestem, silkstem, goldstem, coactiv+, coactiv+, DermaKB and DermaKB Biofilm. Its... see more

Recent & Breaking News (TSXV:KNE)

Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest

Marketwired December 23, 2014

Kane Biotech Announces Second Closing of Private Placement Offering

Marketwired December 17, 2014

Kane Biotech Announces Closing of Private Placement Offering

Marketwired December 9, 2014

Kane Biotech Announces Grant of Options

Marketwired November 19, 2014

Kane Biotech Announces Amendment to Private Placement Offering

Marketwired November 10, 2014

Kane Biotech Appoints Mark Nawacki to the Board of Directors

Marketwired October 8, 2014

Kane Biotech Announces Private Placement Offering

Marketwired October 6, 2014

Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest

Marketwired September 24, 2014

Kane Biotech Provides Business and Patent Update

Marketwired September 23, 2014

Kane Biotech Market Activity

Marketwired September 11, 2014

Microcap Report: Kane Biotech (V.KNE), Atlanta Gold (V.ATG), Orbite Aluminae (T.ORT) active

Stockhouse Editorial July 22, 2014

Kane Biotech (V.KNE) bumps 12% on Health Canada human use approval

Stockhouse Editorial July 22, 2014

Health Canada Approves DispersinB(R) for Human Use

Marketwired July 22, 2014

Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest

Marketwired June 26, 2014

Kane Biotech Announces Grant of Options

Marketwired June 18, 2014

Kane Biotech Announces Board Members

Marketwired June 5, 2014

Kane Biotech Appoints Dr. Sarah Prichard, M.D. to the Board of Directors

Marketwired April 2, 2014

Kane Biotech Appoints Dr. Sarah Prichard, M.D. to the Board of Directors

Marketwired April 2, 2014

Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest

Marketwired April 1, 2014

Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest

Marketwired April 1, 2014